Rekombinanter CD4 (Ibalizumab Biosimilar) Antikörper

Produktnummer ABIN7795119

Der Maus Monoklonal Anti-CD4 (Ibalizumab Biosimilar) Antikörper wurde für FACS und in vivo validiert. Er ist geeignet, CD4 (Ibalizumab Biosimilar) in Proben von Human zu detektieren.

Kurzübersicht für Rekombinanter CD4 (Ibalizumab Biosimilar) Antikörper (ABIN7795119)

Target: CD4 (Ibalizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD4 (Ibalizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-CD4 (Ibalizumab Biosimilar) Antikörper

Expressionssystem: Mammalian cells

Verwendungszweck: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody

Produktmerkmale: What is ibalizumab biosimilar research grade? Ibalizumab Biosimilar uses the same protein sequences as the therapeutic antibody ibalizumab which is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human CD4

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Details zu CD4 (Ibalizumab Biosimilar)

Target: CD4 (Ibalizumab Biosimilar)

Andere Bezeichnung: Ibalizumab Biosimilar

Substanzklasse: Biosimilar